How should respiratory function be monitored in a patient with Myasthenia Gravis in the hospital?

• A. Pulse oximetry
• B. Serial measurements of Forced Vital Capacity
• C. Arterial blood gases
• D. Chest X-ray

Answer: (B)

Monitoring respiratory function in a patient with Myasthenia Gravis is crucial due to the risk of respiratory muscle weakness and potential respiratory failure. Serial measurements of Forced Vital Capacity (FVC) are particularly important in this context. FVC is a measure of how much air a person can exhale after taking a deep breath, which helps assess the strength and endurance of respiratory muscles.

In patients with Myasthenia Gravis, this measurement can help detect a decline in respiratory function early, indicating that the respiratory muscles are becoming weaker. This can guide clinical decision-making regarding interventions such as intubation or mechanical ventilation, should the patient's respiratory muscles deteriorate significantly.

While pulse oximetry, arterial blood gases, and chest X-ray can provide valuable information about respiratory status, they are less specific as primary monitoring tools for muscle function. Pulse oximetry assesses oxygen saturation but does not directly assess muscle strength. Arterial blood gases provide information about gas exchange and acid-base status, but again, they do not measure muscle function directly. A chest X-ray might show some pathological changes but will not reflect the dynamic respiratory capacity or strength of the muscles responsible for breathing.

Thus, serial measurements of Forced Vital Capacity stand out as the preferred method for ongoing